Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

HKG/0241 stock hub

HKG/0241 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0241is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

74.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0241

In the news

Latest news · HKG/0241

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.2

P25 11.7P50 18.9P75 41.4

Trailing P/E35.3

P25 10.7P50 17.9P75 38.5

ROE11.8

P25 -14.7P50 2P75 9.4

ROIC19.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0241 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	HK
Employees	1,357
Employees Change	-7%
Employees Change Percent	-0.51
Enterprise value	HKD 64.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	BMG0171K1018
Last refreshed	2026-05-10
Market cap	HKD 74.4B
Price	HKD 4.6
Price currency	HKD
Rev Per Employee	26,595,230.14x
Sector	Healthcare
Sic	5960
Symbol	hkg/0241
Website	https://www.alihealth.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.84%
EV Earnings	30.43x
EV/EBIT	33.78x
EV/EBITDA	32.74x
EV/FCF	42.72x
EV/Sales	1.78x
FCF yield	2.02%
Forward P/E	26.2x
P/B ratio	3.87x
P/E ratio	35.3x
P/S ratio	2.06x
PE Ratio10 Y	308.68x
PE Ratio3 Y	48.15x
PE Ratio5 Y	56.55x
PEG ratio	0.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.45%
EBITDA Margin	5.55%
FCF margin	4.16%
Gross margin	24.48%
Gross Profit	HKD 8.8B
Gross Profit Growth	8.75%
Gross Profit Growth Q	18.4%
Gross Profit Growth3 Y	11.09%
Gross Profit Growth5 Y	7.23%
Net Income	HKD 2.1B
Net Income Growth	59.97%
Net Income Growth Q	64.72%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	29.76%
Net Income Growth5 Y	29.22%
Pretax Margin	6.57%
Profit Margin	5.84%
Profit Per Employee	HKD 1.6M
Profitable Years	3
ROA	5.16
Roa5y	0.54
ROCE	10.15
ROE	11.76
Roe5y	4.11
ROIC	19.39
Roic5y	-0.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.12%
Cagr15y	10.71%
Cagr1y	-10.34%
Cagr20y	7.62%
Cagr3y	-5.84%
Cagr5y	-27.46%
EPS Growth	51.78
EPS Growth Q	63.6
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	23.9
EPS Growth5 Y	24.67
FCF Growth	90.27%
FCF Growth Q	-0.29%
FCF Growth3 Y	9.15%
FCF Growth5 Y	40.61%
OCF Growth	90.81%
OCF Growth Q	0.23%
OCF Growth10 Y	7.55%
OCF Growth3 Y	8.95%
OCF Growth5 Y	40.43%
Revenue Growth	16.5x
Revenue Growth Q	16.98x
Revenue Growth Quarters	3x
Revenue Growth Years	10x
Revenue Growth3 Y	6.91x
Revenue Growth5 Y	4.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 1.52
Assets	HKD 25.4B
Cash	HKD 10.3B
Current Assets	HKD 17.3B
Current Liabilities	HKD 6.4B
Debt	HKD 83M
Debt EBITDA	HKD 0.04
Debt Equity	HKD 0
Debt FCF	HKD 0.06
Equity	HKD 19.2B
Interest Coverage	993
Liabilities	HKD 6.2B
Long Term Assets	HKD 8.1B
Long Term Liabilities	HKD -153.7M
Net Cash	HKD 10.2B
Net Cash By Market Cap	HKD 13.69
Net Cash Growth	21.48%
Net Debt EBITDA	HKD -5.08
Net Debt Equity	HKD -0.53
Net Debt FCF	HKD -6.77
Tangible Book Value	HKD 18B
Tangible Book Value Per Share	HKD 1.12
WACC	12.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.71
Inventory Turnover	13.46
Net Working Capital	HKD 132.1M
Quick ratio	1.93
Working Capital	HKD 10.4B
Working Capital Turnover	HKD 4.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-10.68%
1Y total return	-10.33%
200-day SMA	5.6
3Y total return	-16.52%
50-day SMA	4.86
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.91%
All Time High	30.15
All Time High Change	-84.74%
All Time High Date	2021-02-18
All Time Low	0.07
All Time Low Change	6,471.43%
All Time Low Date	2002-08-07
ATR	0.15
Beta	1.59
Beta1y	1.22
Beta2y	1.21
Ch YTD	-8.91
High	4.63
High52	7.91
High52 Date	2026-01-14
High52ch	-41.85%
Low	4.52
Low52	4.12
Low52 Date	2025-07-04
Low52ch	11.65%
Ma50ch	-5.33%
Price vs 200-day SMA	-17.87%
RSI	47.46
RSI Monthly	47.39
RSI Weekly	37.13
Sharpe ratio	-0.01x
Sortino ratio	0.12
Total Return	-5.37%
Tr YTD	-8.91
Tr15y	360%
Tr1m	-2.54%
Tr1w	2.91%
Tr3m	-24.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 2B
Operating Income Growth	23.72
Operating Income Growth Q	44.64
Operating Income Growth3 Y	41.49
Operating margin	5.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,888,866,769%
Net Borrowing	-36,458,486.2
Shares Insiders	19.23%
Shares Institutions	15.01%
Shares Out	16,164,999,335
Shares Qo Q	0.17%
Shares Yo Y	5.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.3B
Average Volume	74,904,655.35x
Bv Per Share	1.19
CAPEX	HKD -23.8M
Ch10y	-10.68
Ch15y	360
Ch1m	-2.54
Ch1w	2.91
Ch1y	-10.33
Ch20y	334
Ch3m	-24.59
Ch3y	-16.52
Ch5y	-79.91
Ch6m	-18
Change	-0.43%
Change From Open	0.44
Close	4.62
Days Gap	-0.87
Depreciation Amortization	39,862,506.6
Dollar Volume	332,758,783.6
Earnings Date	2026-05-14
EBIT	HKD 2B
EBITDA	HKD 2B
EPS	HKD 0.13
F Score	6
FCF	HKD 1.5B
FCF EV Yield	2.34x
FCF Per Share	HKD 0.09
Financing CF	-38,784,123
Fiscal Year End	March
Founded	1,998
Goodwill	933,748,354.9
Graham Number	1.86739
Graham Upside	-59.4
Income Tax	HKD 261M
Investing CF	387,605,158
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-09-30
Lynch Fair Value	HKD 3.26
Lynch Upside	-29.08
Ma150	5.6
Ma150ch	-17.84%
Ma20	4.56
Ma20ch	0.94%
Net CF	1,864,842,305
Next Earnings Date	2026-05-14
Open	4.58
P FCF Ratio	49.5
P OCF Ratio	48.73
Position In Range	72.73
Ppne	125,938,390
Price Date	2026-05-08
Price EBITDA	HKD 37.12
Ptbv Ratio	4.13
Relative Volume	1x
Revenue	36,089,727,299x
SBC By Revenue	0.6x
Share Based Comp	217,217,099
Tax By Revenue	0.72x
Tax Rate	11.01%
Tr20y	333.96%
Tr6m	-18%
Volume	72,338,866
Z Score	9.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/0241 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/0241 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0241?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.0%

Share of float held by funds and institutions

Insider ownership

+19.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.4%

Negative means the company is buying back shares.

Technical

HKG/0241 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.5

Neutral momentum band

Price vs 200-day MA

-17.9%

50/200-day relationship not available

Beta (5Y)

1.59

More volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0241

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0241 stock rating?

hkg/0241 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0241 analysis?

The full report lives at /stocks/hkg/0241/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0241?

The latest report frames hkg/0241 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0241 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.